China Biologic Products Company Profile (NASDAQ:CBPO)

Analyst Ratings

Consensus Ratings for China Biologic Products (NASDAQ:CBPO) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $142.33 (28.65% upside)

Analysts' Ratings History for China Biologic Products (NASDAQ:CBPO)
Show:
DateFirmActionRatingPrice TargetActions
7/22/2016Jefferies GroupReiterated RatingBuy$136.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/5/2016Credit Suisse Group AGUpgradeNeutral -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2016Deutsche Bank AGBoost Price TargetBuy$149.00 -> $162.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/9/2015Bank of America Corp.Initiated CoverageBuy$135.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/3/2014AegisReiterated RatingBuy$55.00 -> $59.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/25/2014 forward)

Earnings

Earnings History for China Biologic Products (NASDAQ:CBPO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/5/2016        
5/4/2016Q116$0.88$0.94$74.00 million$85.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2016Q415$0.55$0.74$66.77 million$68.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2015Q315$0.81$0.82$75.30 million$78.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2015Q215$0.87$1.06$71.75 million$79.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2015Q1 15$0.84$0.87ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/4/2015Q4 14$0.51$0.48ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2014Q114$0.47$0.69$51.40 million$56.27 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/12/2014Q413$0.38$0.35$41.50 million$42.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2013Q313$0.42$0.56$47.20 million$53.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/8/2012Q312$0.54$41.30 million$53.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for China Biologic Products (NASDAQ:CBPO)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for China Biologic Products (NASDAQ:CBPO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for China Biologic Products (NASDAQ:CBPO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/8/2016Wp X Biologics LlcDirectorSell2,775,000$111.00$308,025,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2016Ming YangCFOSell13,908$113.64$1,580,505.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2016Ming YinVPSell19,618$113.64$2,229,389.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2016Zhijing Cbpo LiuVPSell282$108.00$30,456.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/7/2016Wp X Biologics LlcDirectorSell4,257,000$107.00$455,499,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/7/2015Zhijun TongDirectorSell15,000$118.33$1,774,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/4/2015David GaoCEOSell95,991$115.60$11,096,559.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/2/2015David GaoCEOSell12,891$112.26$1,447,143.66View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2015David GaoCEOSell71,118$110.21$7,837,914.78View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/26/2015David GaoCEOSell59,542$105.22$6,265,009.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/20/2015David GaoCEOSell258$105.00$27,090.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/19/2015David GaoCEOSell200$105.03$21,006.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2015Ming YangCFOSell9,000$94.56$851,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2015Ming YinVPSell20,508$95.55$1,959,539.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/14/2015Ming YangCFOSell11,304$97.08$1,097,392.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/14/2015Wenfang LiuDirectorSell2,717$97.02$263,603.34View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/14/2015Zhijing Cbpo LiuVPSell6,786$99.29$673,781.94View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2015Wp X Biologics LlcDirectorSell2,645,000$100.28$265,240,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/21/2014Zhijing Cbpo LiuVPSell8,000$68.95$551,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2014Sean ShaoDirectorSell72,500$62.75$4,549,375.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2014Zhijing Cbpo LiuVPSell7,500$62.75$470,625.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2014Gang Cbpo YangVPSell2,454$54.00$132,516.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2014Ming YangCFOSell6,164$54.00$332,856.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/12/2014Ming YinVPSell3,073$54.00$165,942.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/12/2013Wenfang LiuDirectorSell2,524$25.00$63,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2013Wp X Biologics LlcDirectorBuy3,112,920$20.00$62,258,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for China Biologic Products (NASDAQ:CBPO)
DateHeadline
07/23/16 07:23 AMEquity Roundup: Stock Performance Focus on China Biologic Products, Inc. (NASDAQ:CBPO) - Press Telegraph
07/22/16 07:58 AMChina Biologic Products to Report Second Quarter 2016 Financial Results - [at noodls] - BEIJING, July 22, 2016/PRNewswire / -- China Biologic Products, Inc. (NASDAQ: CBPO, 'China Biologic' or the 'Company'), a leading fully integrated plasma-based biopharmaceutical company in China, today ...
07/20/16 10:23 PMChina Biologic Products, Inc. (NASDAQ:CBPO): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/20/16 10:23 PMShares Turning Downward: China Biologic Products, Inc. (NASDAQ:CBPO) - TGP
07/20/16 11:09 AMHow Analysts Feel About China Biologic Products Inc (NASDAQ:CBPO)? - Consumer Eagle
07/19/16 08:29 PMLong Term Value Play: China Biologic Products, Inc. (NASDAQ:CBPO) - TGP
07/19/16 03:10 PMCutler Group Lp buys $6963821 stake in China Biologic Products Inc (CBPO) - Trade Calls
07/18/16 07:21 AMChina Biologic Products, Inc. breached its 50 day moving average in a Bearish Manner : CBPO-US : July 18, 2016 -
07/15/16 06:31 PMNew Broker Ratings For China Biologic Products, Inc. (NASDAQ:CBPO) - FTSE News
07/14/16 08:32 PMChina Biologic Products Inc Realized Volatility Hits Extremely Low Level - CML News
07/14/16 09:47 AMChina Biologic Products, Inc. (NASDAQ:CBPO) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/12/16 07:19 AMStock for the Ages: China Biologic Products, Inc. (NASDAQ:CBPO) - Telanagana Press
07/12/16 07:19 AMHow Many China Biologic Products Inc (NASDAQ:CBPO)'s Analysts Are Bullish? - Press Telegraph
07/11/16 03:04 PMWall Street Ratings and Target Price Views on China Biologic Products, Inc. (NASDAQ:CBPO) - Telanagana Press
07/11/16 03:04 PMIs $162 Within Reach For China Biologic Products, Inc. (NASDAQ:CBPO)? - Investor Newswire
07/10/16 02:59 PMNext Weeks Broker Price Targets For China Biologic Products, Inc. (NASDAQ:CBPO) - Fiscal Standard
07/09/16 07:31 AMChina Biologic Products Breaks Above 200-Day Moving Average - Bullish for CBPO - Nasdaq
07/08/16 03:06 PMBRIEF-Capital Research Global Investors reports 11.3 pct passive stake in China Biologic Products
07/08/16 03:06 PMChina Biologic Products Breaks Above 200-Day Moving Average - Bullish for CBPO
07/08/16 07:08 AMChina Biologic Products, Inc. breached its 50 day moving average in a Bullish Manner : CBPO-US : July 8, 2016 -
07/07/16 03:05 PMShares Declining and Worrying Investors: China Biologic Products, Inc. (NASDAQ:CBPO) - Telanagana Press
07/07/16 03:05 PMChina Biologic Products, Inc. Stock Momentum at Critical Inflection Point - CML News
07/06/16 08:53 PMLong Term Growth Stock: China Biologic Products, Inc. (NASDAQ:CBPO) - Telanagana Press
07/06/16 08:53 PMCan China Biologic Products, Inc. (NASDAQ:CBPO) Improve on the Earnings Front? - Engelwood Daily
07/04/16 02:57 PMBroker Outlook For The Week Ahead China Biologic Products, Inc. (NASDAQ:CBPO) - Fiscal Standard
07/04/16 08:36 AMCan You Expect Monetary Easing in China post-Brexit? -
07/04/16 07:58 AMChina Biologic Products, Inc. (NASDAQ:CBPO) Expected to Reach Highs Of $162 - Investor Newswire
07/01/16 05:01 PMETF’s with exposure to China Biologic Products, Inc. : July 1, 2016 -
07/01/16 03:06 PMWhat Are the Chief Causes behind GSAGX’s Terrible 2016?
07/01/16 11:10 AMRudman Errol M Decreased Stake in China Biologic Prods INC (NASDAQ:CBPO) by $5.12 Million as Shares Declined - Engelwood Daily
07/01/16 11:10 AMRecently Issued Stock Ratings For China Biologic Products, Inc. (NASDAQ:CBPO) - Fiscal Standard
06/28/16 02:26 PMCovering the Bases on China Biologic Products, Inc. (NASDAQ:CBPO): Where is the Stock Going? - Press Telegraph
06/27/16 07:43 AMStrong Sell Calls Recommendations For China Biologic Products, Inc. (NASDAQ:CBPO) At 0 - Investor Newswire
06/27/16 07:43 AMChina Biologic Products, Inc. (NASDAQ:CBPO) Broker Price Targets For The Coming Week - Fiscal Standard
06/25/16 04:07 AMOversold Conditions For China Biologic Products (CBPO) - Nasdaq
06/24/16 03:12 PMOversold Conditions For China Biologic Products (CBPO)
06/20/16 01:09 PMETF’s with exposure to China Biologic Products, Inc. : June 20, 2016 -
06/20/16 09:28 AMChina Biologic Opens Plasma Collection Station in Hebei Province - PR Newswire (press release)
06/20/16 09:28 AMStrong Buy Calls Count For China Biologic Products, Inc. (NASDAQ:CBPO) At 3 - Investor Newswire
06/20/16 07:59 AMChina Biologic Opens Plasma Collection Station in Hebei Province - [at noodls] - BEIJING, June 20, 2016/PRNewswire / -- China Biologic Products, Inc. (NASDAQ: CBPO, 'China Biologic' or the 'Company'), a leading fully integrated plasma-based biopharmaceutical company in China, today ...
06/20/16 07:46 AMCHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other Events, -
06/19/16 02:58 PMThis Weeks Broker Views For China Biologic Products, Inc. (NASDAQ:CBPO) - Fiscal Standard
06/14/16 07:23 AMNotable Two Hundred Day Moving Average Cross - CBPO
06/13/16 07:01 AMCHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Regulation FD Disclosure -
06/12/16 08:24 PMTrend Of Rating Given To China Biologic Products, Inc. (NASDAQ:CBPO) - Investor Newswire
06/08/16 11:37 AMChina Biologic Products, Inc. (NASDAQ:CBPO) Updated Price Targets - FTSE News
06/07/16 07:07 AMChina Biologic Products, Inc. breached its 50 day moving average in a Bullish Manner : CBPO-US : June 7, 2016 -
06/06/16 03:33 PMCHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial -
06/06/16 02:55 PMNotable Stocks within Investor Radar China Biologic Products, Inc. (NASDAQ:CBPO) , Molina Healthcare Inc (NYSE ... - Street Updates
06/04/16 03:03 PMChina Biologic Products announces secondary offering of commonstock - DEALSTREETASIA

Social

About China Biologic Products

China Biologic Products logoChina Biologic Products, Inc. (China Biologic) is a biopharmaceutical company. The Company is principally engaged in the research, development, manufacturing and sales of human plasma-based biopharmaceutical products in China. It operates in the manufacture and sales of human plasma products segment. It has a product portfolio with over 20 various dosage forms of plasma products and other biopharmaceutical products across over nine categories. Its principal products are human albumin and immunoglobulin for intravenous injection (IVIG). China Biologic operates its business through approximately two subsidiaries, namely, Shandong Taibang Biological Products Co. Ltd. and Guizhou Taibang Biological Products Co., Ltd. The Company also holds an interest in Xi'an Huitian Blood Products Co., Ltd., a plasma products company. Its products also include Human rabies immunoglobulin, Human tetanus immunoglobulin, Placenta polypeptide, Factor VIII and Human prothrombin complex concentrate.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CBPO
  • CUSIP:
Key Metrics:
  • Previous Close: $109.81
  • 50 Day Moving Average: $110.59
  • 200 Day Moving Average: $116.00
  • P/E Ratio: 33.10
  • P/E Growth: 1.32
  • Market Cap: $2.94B
  • Beta: 1.74
  • Current Year EPS Consensus Estimate: $3.97 EPS
  • Next Year EPS Consensus Estimate: $4.7 EPS
Additional Links:
China Biologic Products (NASDAQ:CBPO) Chart for Monday, July, 25, 2016